Abstract
We looked for p16 gene deletion by Southern analysis and p16 gene point mutation by single-stranded conformation polymorphism (SSCP) analysis and direct sequencing of DNA from fresh tumour samples of 35 and 33 breast carcinomas respectively. No homozygous p16 gene deletion was found in any case. A missense point mutation of the p16 gene was found in only one patient. This point mutation was absent from the patient's lymphocytes, ruling out a polymorphism or a germline mutation. These findings suggest that p16 gene alterations are rarely observed in breast carcinoma.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quesnel, B., Fenaux, P., Philippe, N. et al. Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 72, 351–353 (1995). https://doi.org/10.1038/bjc.1995.337
Issue Date:
DOI: https://doi.org/10.1038/bjc.1995.337
This article is cited by
-
Methylation status of p16 INK4A tumor suppressor gene in Iranian patients with sporadic breast cancer
Journal of Cancer Research and Clinical Oncology (2009)
-
Mutation and abnormal expression of P16INK4a in hepatocellular carcinoma
Chinese Journal of Cancer Research (1999)
-
Alterations of p16-pRb Pathway and Chromosome Locus 9p21–22 in Sporadic Invasive Breast Carcinomas
Molecular Medicine (1998)